I think the bit in the Euroz Hartleys report that stood out like dogs balls to me was:
"For illustrative purposes, the incorporation of Nova Phase production (diversion of ~4ktpa of Stage 2 HPA sales to Nova Phase feedstock) into our valuation from FY29E onwards lifts our valuation to +$3.50/sh on base case EBITDA margins."
Now that's a few years off, but provides an indication of the potential value if they get things right...
Ann: $40M Strategic Placement to Accelerate Alpha Sapphire, page-31
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A4N (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
86.8¢ |
Change
-0.013(1.42%) |
Mkt cap ! $871.7M | |||
| Open | High | Low | Value | Volume |
| 88.0¢ | 88.3¢ | 86.0¢ | $352.8K | 405.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 9067 | 86.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 87.0¢ | 14430 | 32 |
View Market Depth
| Last trade - 14.11pm 19/06/2024 (20 minute delay) ? |
| A4N (ASX) Chart |